Call to arrange a consultation
+1 416 777 0888
Search the site
Gilead Sciences, Inc. et al v. JAMP Pharma Corporation
2022
T-1607-22
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,845,553 and 2,990,210 (tenofovir alafenamide/emtricitabine).
Counsel to:
JAMP Pharma Corporation
The decision is reported
here.
Meet the team
